Tagged with R

Turkey Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of Health in the country, in addition to offering a deep analysis of his assessment of the cardiology landscape, and why…

Metos Rupert Mok, a veteran of the Hong Kong medtech industry, discusses regulatory alignment between Hong Kong and mainland China, opportunities for collaboration, the consumer ‘wearable’ space, and the state of the territory’s start-up ecosystem.   Having worked in the Hong Kong medical device and equipment industry for three decades now,…

UK After spending five years heading market access globally, Lars Bruening returned to a country manager role in the UK; he shares with us his thoughts on Brexit while also highlighting exciting Phase III developments and introducing the new Baylab opened by Bayer in Reading (near London).   It is this…

Turkey Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in her second general manager position, sets out her priorities, comments on the marriage of Turkish and Japanese work practices, and…

Spain Josep Taberno MD PhD, director of VHIO, introduces the important work being conducted by the cancer institute in Spain as well as emerging trends in oncology. Can you tell us about VHIO? “ The complexities in cancer treatment and care are myriad. That said, I firmly believe that we can…

Hong Kong Ingrid Reinli, general manager of the European Chamber of Commerce in Hong Kong, discusses the chamber´s strategic priorities and how it serves to unify the European presence in the market. She also reflects on the relationship between Hong Kong and the many European countries investing into the region. Why did…

UK Thomas Broeer, managing director UK and Ireland for Aurobindo, has been at the helm of Aurobindo’s UK subsidiary, Milpharm Limited for almost two years and here discusses the UK market’s strengths, the potential impact of Brexit on the pharmaceutical industry and the pricing structures in place in the UK.  …

Turkey Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the next steps ahead to further improve access to innovation in Turkey and ensure the country continues to be seen as…

Belun Technology Lydia Leung, CEO of Belun Technology, introduces us to the start-up´s flagship product, the Belun Ring. She also discusses the impact that Artificial Intelligence (AI) and preventative care can have on the healthcare industry in Hong Kong. Having been in a government research institute for ten years before joining Belun…

Hong Kong Merck Hong Kong’s Hee-sun Lee gives her first impressions of the Hong Kong market, her main priorities, upcoming product launches and tapping into the territory’s R&D ecosystem. Hee-sun, having joined Merck Pharmaceutical Hong Kong in February 2018 from the South Korean affiliate, what are your first impressions of the market…

Asia-Pacific Kevin O’Reilly, president for the APAC region at medtech giant Varian, discusses his key priorities, the importance of Asia to the global group, new technology adoption, and the importance of inter-stakeholder collaboration.   Diversity has been a major factor in our interest in this region, and by becoming closer to…

Portugal Francisco del Val, recently nominated general manager of the business unit Sanofi Genzyme and country head of Sanofi Portugal, has two decades’ experience in the pharma industry. In his first interview in Portugal, Francisco shares with us his priorities and his vision, highlighting the importance of diversification, and innovation through…